Omega Healthcare Investors OHI Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $655.98M+42.4% | $609.47M+45.9% | $553.96M+54.8% | $483.92M+43.7% | $460.52M+63.7% | ||
| $329.51M+6.3% | $325.25M+6.8% | $321.11M+6.4% | $316.24M+3.6% | $309.97M-1.0% | ||
| $38.97M-10.0% | $44.19M+20.4% | $43.52M+20.0% | $43.33M+20.6% | $43.28M+21.7% | ||
| $60.25M+145% | $67.3M+411% | $63.12M+201% | $34.61M-47.0% | $24.63M-61.9% | ||
| -$6.05M+67.9% | $2.34M+115% | -$4.31M-124% | -$9.46M-132% | -$18.86M-133% | ||
| —— | —— | -$44.36M-189% | -$43.32M— | -$27.15M— | ||
| $912.1M+16.9% | $878.55M+17.2% | $876.9M+27.9% | $835.07M+24.3% | $779.91M+18.6% | ||
| $69.45M+36.2% | $80.87M+114% | $69.66M+88.3% | $56.69M+46.0% | $50.99M+28.7% | ||
| $244.66M-47.2% | $173.57M-63.1% | $338M-25.0% | $386.59M-10.3% | $463.01M+5.8% | ||
| $218.07M+11,234% | $122.09M+12,473% | $77.82M+13,552% | $1.9M-57.5% | $1.92M— | ||
| -$829.07M-37.2% | -$539.79M+19.6% | -$809.82M— | -$859.48M— | -$604.45M— | ||
| $789.59M+11.2% | $780.39M+13.9% | $763.44M+14.2% | $738.51M+11.9% | $709.91M+9.0% | ||
| —— | —— | —— | —— | —— | ||
| $2.03B+35.1% | $1.9B+65.6% | $531.01M-61.3% | $782.41M-49.2% | $1.5B+94.1% | ||
| $450.97M-69.2% | $606.81M-50.9% | $1.04B+28.6% | $1.48B+261% | $1.46B+299% | ||
| —— | —— | —— | —— | —— | ||
| -$436.24M-222% | -$838.26M-3,285% | $345.62M+157% | $752.8M+182% | -$135.36M— | ||
| —— | —— | —— | $5.06M— | $945K— | ||
| -$350.75M-955% | -$494.17M-575% | $414.69M— | $733.45M— | $41.05M— | ||
| —— | —— | $5.02M-66.0% | $6.01M-62.9% | $8.57M-46.1% | ||
| $6.26M+526% | $6.13M+215% | $11.97M— | $3.4M— | $999K— | ||
| $60.25M+145% | $67.3M+411% | $63.12M+201% | $34.61M-47.0% | $24.63M-61.9% | ||
| $21.77M+10.1% | $22.61M-5.1% | $18.33M-29.6% | $25.81M-43.0% | $19.77M-66.1% | ||
| —— | —— | —— | $1.19M-27.5% | $3.19M+8.9% | ||
| —— | —— | —— | —— | —— | ||
| -$17.67M-70.6% | -$13.59M-18.6% | -$11.77M+5.2% | -$9.79M+23.7% | -$10.36M+16.4% | ||
| $26.01M— | $26.28M— | —— | —— | —— | ||
| -$6.05M+67.9% | $2.34M+115% | -$4.31M-124% | -$9.46M-132% | -$18.86M-133% | ||
| —— | —— | —— | —— | —— | ||
| $69.45M+36.2% | $80.87M+114% | $69.66M+88.3% | $56.69M+46.0% | $50.99M+28.7% | ||
| $22.57M-67.5% | $33.59M-51.3% | $41.17M-44.9% | $56.56M-21.4% | $69.56M+28.3% | ||
| —— | —— | —— | —— | —— | ||
| -$3.92M— | -$4.24M— | —— | —— | —— | ||
| $749.66M+65.2% | $683.03M+67.2% | $806.67M+187% | $841.08M+257% | $453.73M+82.0% | ||
| $218.07M+11,234% | $122.09M+12,473% | $77.82M+13,552% | $1.9M-57.5% | $1.92M— | ||
| $244.66M-47.2% | $173.57M-63.1% | $338M-25.0% | $386.59M-10.3% | $463.01M+5.8% | ||
| $15.16M— | $12.91M— | —— | —— | —— | ||
| $196.38M-4.6% | $282.78M+198% | $290.35M-26.0% | $233.15M-58.9% | $205.84M-64.4% | ||
| $46.82M+25.2% | $43.89M+50.0% | $39.72M+38.7% | $38.6M+36.2% | $37.41M+34.9% | ||
| —— | $2.2M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $450.97M-69.2% | $606.81M-50.9% | $1.04B+28.6% | $1.48B+261% | $1.46B+299% | ||
| —— | —— | —— | —— | —— | ||
| $8.18M+362% | $6.83M+122% | $5.9M+148% | $1.81M-61.5% | $1.77M-77.7% | ||
| —— | —— | —— | —— | —— | ||
| $842.65M+15.6% | $797.68M+12.1% | $807.24M+24.5% | $778.38M+23.0% | $728.92M+17.9% | ||
| $842.65M+15.6% | $797.68M+12.1% | $807.24M+24.5% | $778.38M+23.0% | $728.92M+17.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Omega Healthcare Investors generate?
- Omega Healthcare Investors (OHI) generated $912.1M in operating cash flow over the trailing twelve months.
- What is Omega Healthcare Investors's free cash flow?
- After $69.5M of capital expenditures, Omega Healthcare Investors's free cash flow was $842.6M over the trailing twelve months, up 15.6% year over year.
- Where does Omega Healthcare Investors's cash flow data come from?
- Every line is extracted from Omega Healthcare Investors's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
